- |||||||||| cyclosporin A microemulsion / Generic mfg.
Trial completion, Enrollment change, Trial initiation date: Ciclosporin in the Management of New Type 1 Reactions in Leprosy (clinicaltrials.gov) - Mar 24, 2015 P2/3, N=73, Completed, Not yet recruiting --> Completed | N=100 --> 73 | Initiation date: Aug 2009 --> Aug 2010
- |||||||||| cyclosporin A microemulsion / Generic mfg.
Trial completion, Trial initiation date: Ciclosporin in the Management of New Erythema Nodosum Leprosum (clinicaltrials.gov) - Mar 24, 2015 P2, N=12, Completed, Not yet recruiting --> Completed | N=100 --> 73 | Initiation date: Aug 2009 --> Aug 2010 Not yet recruiting --> Completed | Initiation date: Jul 2009 --> Jul 2010
- |||||||||| Infanrix Hexa (diphtheria tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis, adsorbed conjugated Haemophilus influenzae type b vaccine) / GSK
Phase classification, Enrollment change: Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules (clinicaltrials.gov) - Mar 23, 2015 P2, N=1885, Completed, Not yet recruiting --> Completed | Initiation date: Jul 2009 --> Jul 2010 Phase classification: P2/3 --> P2 | N=1467 --> 1885
- |||||||||| Shanchol (oral cholera vaccine) / Sanofi
Trial primary completion date: ROCV: Oral Cholera Vaccine Delivery in Rural Bangladesh (clinicaltrials.gov) - Mar 7, 2015 P=N/A, N=60000, Recruiting, Recruiting --> Completed Trial primary completion date: Aug 2014 --> Aug 2015
- |||||||||| Enrollment closed, Trial primary completion date: Phase III Clinical Study of Efficacy and Safety of Vaccae (clinicaltrials.gov) - Mar 7, 2015
P3, N=10000, Active, not recruiting, Trial primary completion date: Jan 2015 --> Apr 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2016 --> Jan 2016
- |||||||||| Mycobutin (rifabutin) / Pfizer, Lupin
Enrollment closed, Trial primary completion date: Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients (clinicaltrials.gov) - Mar 2, 2015 P4, N=500, Active, not recruiting, Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Sep 2017 --> Nov 2015 Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Mar 2015
- |||||||||| Menveo (meningococcal-groups A, C, W-135 and Y oligosaccharide CRM197 conjugate vaccine) / GSK
Trial completion: Safety of MenACWY-CRM Vaccination in Adolescents (clinicaltrials.gov) - Feb 27, 2015 P=N/A, N=55397, Completed, Phase classification: P3 --> P=N/A | N=50 --> 370 Active, not recruiting --> Completed
- |||||||||| Trial initiation date, Trial primary completion date: Efficacy of Propolis Varnish Against Oral Biofilm (clinicaltrials.gov) - Feb 26, 2015
P2, N=15, Not yet recruiting, Initiation date: Sep 2012 --> Dec 2012 Initiation date: Sep 2014 --> Jan 2016 | Trial primary completion date: Oct 2014 --> Jul 2016
- |||||||||| pretomanid (PA-824) / Global Alliance for TB Drug Development
Enrollment open: STAND: Shortening Treatment by Advancing Novel Drugs (clinicaltrials.gov) - Feb 20, 2015 P3, N=1500, Recruiting, Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||||||| Menveo (meningococcal-groups A, C, W-135 and Y oligosaccharide CRM197 conjugate vaccine) / GSK
Enrollment closed: Safety of MenACWY-CRM Vaccination in Adolescents (clinicaltrials.gov) - Feb 19, 2015 P=N/A, N=55429, Active, not recruiting, Recruiting --> Active, not recruiting Completed --> Active, not recruiting
- |||||||||| Shanchol (oral cholera vaccine) / Sanofi
Trial primary completion date: ICVB: Introduction of Cholera Vaccine in Bangladesh (clinicaltrials.gov) - Feb 19, 2015 P=N/A, N=240000, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2015
- |||||||||| Enrollment change, Trial termination: Immunobiology of Diabetes and Tuberculosis (clinicaltrials.gov) - Feb 13, 2015
P=N/A, N=10, Terminated, Recruiting --> Completed | N=6000 --> 8962 | Trial primary completion date: Jan 2014 --> Dec 2014 N=34 --> 10 | Active, not recruiting --> Terminated; Additional funding was not secured
|